This study aimed to determine the efficiency of PIM kinase inhibition in PTCL, to explore the molecular response of PTCL cells to pharmacological pan-PIM inhibition and to identify those PTCL subgroups that are more susceptible to PIM inhibition. The gene discussed is PIM1; the disease is mature T-cell and NK-cell non-Hodgkin lymphoma.